Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVES: This study aimed to develop and validate a clinically motivated artificial intelligence framework for preoperative risk assessment of the second mesiobuccal (MB2) canal in maxillary first molars using panoramic radiographs. MATERIALS AND METHODS: A total of 388 panoramic radiographs were retrospectively collected. Stage 1 used YOLOv5 to localize maxillary first molars and crop tooth-le...
BACKGROUND: Portal vein tumor thrombus is a lethal complication of HCC for which effective biomarkers are urgently needed. METHODS: Through proteomic profiling, functional and mechanistic assays, and machine learning-based evaluation of serum NSUN6 in 472 HCC patients with external validation (n = 98), we characterized an epitranscriptomic regulator of HCC metastasis. RESULTS: NSUN6 was downregula...
INTRODUCTION: The search for actionable genetic targets in cancer has evolved substantially over the past decade. Earlier approaches were focused on s...
OBJECTIVE: The aim of this study was to integrate multimodal intratumoral and peritumoral ultrasound radiomic features with clinical data to construct...
BACKGROUND: Prescription dose selection for intracranial meningiomas treated with stereotactic radiosurgery remains guided by tumor volume, anatomical...
PURPOSE: Response to neoadjuvant chemoradiotherapy (nCRT) in rectal cancer remains heterogeneous. This exploratory study evaluated whether radiomics f...
OBJECTIVES: This study aimed to develop and validate a CBCT-based automated system for assessing radiographic alveolar bone loss (RBL) to improve the ...
Over the past three decades, adenosine signalling has emerged as a fundamental regulatory system controlling immune responses, tissue homeostasis, met...
Triple-negative breast cancer (TNBC), being one of the most aggressive subtypes of breast malignancies, is characterized by poor prognosis and limited...
BACKGROUND: Understanding how lifestyle habits influence breast cancer survival is crucial for improving long-term outcomes and guiding individualized...
Hypoxia, a hallmark of solid tumors, drives malignant progression and represents a major therapeutic challenge. Metabolic reprogramming induced by hyp...
Cancer is a global public health problem that poses a huge threat to human life and health. The identification of cancer driver genes helps to discove...
Late distant recurrence (DR) remains a persistent risk in hormone receptor-positive (HR+) early breast cancer after completion of 5 years of endocrine...
BACKGROUND: Ovarian cancer (OVCA) is a common and highly aggressive gynecologic malignancy often diagnosed at advanced stages. Approximately 30% of pa...
BACKGROUND: Radiation-induced erectile dysfunction (RIED) remains one of the most prevalent and distressing late toxicities among prostate cancer surv...
BACKGROUND AND AIMS: Tertiary lymphoid structures (TLS) are associated with heterogeneous outcomes in hepatocellular carcinoma (HCC), but whether thei...
Estrogen receptor 1 (ESR1) is an established oncogenic transcription factor in breast and endometrial cancer; however, more is known about the mechani...
RATIONALE AND OBJECTIVES: The distance of spread through air spaces (STAS) dissemination is associated with prognosis in lung adenocarcinoma (LUAD). T...
RATIONALE AND OBJECTIVES: Although accurate preoperative prediction of sentinel lymph node (SLN) status in operable early-stage breast cancer (EBC) af...
OBJECTIVE: Lateral cervical lymph node metastasis (LLNM) is missed in up to 30% of papillary thyroid carcinoma (PTC) patients pre-operatively, leading...